BioCryst Maintains Orladeyo FY2026 Guidance, Raises Total Revenue Outlook
BioCryst maintained FY2026 Orladeyo revenue guidance at $625 million-$645 million and increased total revenue guidance to $715 million-$730 million.
Related stories
eMudhra Reports September-Quarter Consolidated Net Profit of 327.6 Million Rupees
L impact | EARNINGS | Nov 04, 2026, 02:03 PM UTC
MGE Energy reports third-quarter EPS of $1.48
L impact | EARNINGS | Nov 04, 2026, 02:00 PM UTC
MGE Energy Reports Third-Quarter Net Income of $56.4M
L impact | EARNINGS | Nov 04, 2026, 02:00 PM UTC
G R Infraprojects Reports September-Quarter Revenue of 23.25 Billion Rupees
L impact | EARNINGS | Nov 04, 2026, 01:59 PM UTC
G R Infraprojects Reports September-Quarter Consolidated Net Profit of 2.93 Billion Rupees
M impact | EARNINGS | Nov 04, 2026, 01:58 PM UTC
Pandora Raises 2026 EBIT Margin Guidance to 22.5%-23%
Pandora raised its 2026 EBIT margin guidance to 22.5%-23%.
M impact | EARNINGS | Nov 04, 2026, 01:57 PM UTC